Clinical Trial Update: Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating lenalidomide and dexamethasone with or without stem cell transplant in patients with multiple myeloma has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Columbia University | Conditions: Multiple Myeloma | Phase 4 | Status: COMPLETED | Results posted: 2019-10-15